GlobeNewswire Inc | Dec 28, 2021 04:05PM EST

December 28, 2021

ALISO VIEJO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual J.P. Morgan Healthcare Conference.

RxSight management is scheduled to present Thursday, January 13, 2022, at 6:45am PT / 9:45am ET. Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.rxsight.com/.

About RxSight, Inc.RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:Philip Taylor Gilmartin Group415.937.5406IR@rxsight.com